CRIEX
Price
$8.51
Change
+$0.20 (+2.41%)
Updated
Jun 2 closing price
Net Assets
19.67M
FSMAX
Price
$115.66
Change
+$1.23 (+1.07%)
Updated
Jun 2 closing price
Net Assets
42.73B
Interact to see
Advertisement

CRIEX vs FSMAX

Header iconCRIEX vs FSMAX Comparison
Open Charts CRIEX vs FSMAXBanner chart's image
CRIEX vs FSMAX Comparison Chart in %
View a ticker or compare two or three
VS
CRIEX vs. FSMAX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIEX is a Buy and FSMAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 42.7B vs. CRIEX (19.7M). FSMAX pays higher dividends than CRIEX: FSMAX (0.50) vs CRIEX (0.00). CRIEX was incepted earlier than FSMAX: CRIEX (20 years) vs FSMAX (15 years). CRIEX (1.35) is less costly to investors than FSMAX (0.04). CRIEX is a more actively managed with annual turnover of: 26.00 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than CRIEX: FSMAX (0) vs CRIEX (1000000). FSMAX annual gain was more profitable for investors over the last year : 30.51 vs. CRIEX (26.87). FSMAX return over 5 years is better than : 37.00 vs. CRIEX (-9.06).
CRIEXFSMAXCRIEX / FSMAX
Total Expense Ratio1.200.043,429%
Annual Report Gross Expense Ratio1.350.043,857%
Fund Existence20 years15 years-
Gain YTD14.14813.668104%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.7M42.7B0%
Annual Yield % from dividends0.000.50-
Returns for 1 year26.8730.5188%
Returns for 3 years30.8571.5343%
Returns for 5 years-9.0637.00-24%
Returns for 10 years0.59141.360%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIGGX50.16N/A
N/A
American Funds Intl Gr and Inc R6
CMUAX16.93N/A
N/A
Columbia Select Mid Cap Value A
GPGIX3.89N/A
N/A
Grandeur Peak Global Opportunities Instl
CIGYX11.36N/A
N/A
AB International Growth Advisor
HFDRX20.81N/A
N/A
Hartford Schroders US MidCap Opps R3